ExploreWatchlistsPricing
  1. US-listed companies
  2. Eloxx Pharmaceuticals, Inc.
  3. Financials
  4. Net income

Eloxx Pharmaceuticals, Inc. (ELOX)

Market cap
$92.56M
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2025-6-83.38%
Dec 31, 2022-36-45.95%
Dec 31, 2021-67+92.98%
Dec 31, 2020-35-32.03%
Dec 31, 2019-51+7.82%
Dec 31, 2018-47+122.42%
Dec 31, 2017-21+265.99%
Jun 30, 2017-6-29.89%
Jun 30, 2016-8-54.23%
Jun 30, 2015-18+95.81%
Jun 30, 2014-9+50.68%
Jun 30, 2013-6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat